Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide

Acromegaly is a disease due to chronic GH excess and a consequent rise in IGF-1 levels. This rare endocrine condition is associated with metabolic alterations such as hyperglycaemia, dyslipidaemia, and systemic arterial hypertension, which, in addition to GH excess-related cardiovascular changes, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Puglisi, Soraya, Ferraù, Francesco, Ragonese, Marta, Spagnolo, Federica, Cannavò, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017075/
https://www.ncbi.nlm.nih.gov/pubmed/32117056
http://dx.doi.org/10.3389/fendo.2020.00028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017075/
https://www.ncbi.nlm.nih.gov/pubmed/32117056
http://dx.doi.org/10.3389/fendo.2020.00028

Ejemplares similares